Time course of changes in the biochemical composition of peripheral lymph in breast cancer
https://doi.org/10.17650/1994-4098-2011-0-4-37-41
Abstract
Many studies show that there are blood composition changes in the development of malignances. Nonetheless, to study changes in
chemical composition of peripheral lymph is also an urgent problem. This paper presents the results of studying the biochemical composition of peripheral lymph in 78 patients after mastectomy or breast resection in different breast stages. The study estimated the peripheral lymph concentrations of the following indicators: total protein, albumin, globulin, fibrinogen, bilirubin, cholesterol, urea, creatinine, glucose, sodi- um, potassium, alanine aminotransferase and aspartate aminotransferase, and alkaline phosphatase. The findings suggest that considerable peripheral lymph changes occur in cancer patients, which shows the need for timely diagnosis and correction.
About the Authors
Sh. Kh. Gantsev
Bashkir State Medical University;
Republican Clinical Oncology Dispensary, Ufa, Republic of Bashkortostan
Russian Federation
Russian Federation
A. V. Sultanbayev
Bashkir State Medical University
Russian Federation
Russian Federation
R. Sh. Ishmuratova
Bashkir State Medical University
Russian Federation
Russian Federation
V. Yu. Frolova
Republican Clinical Oncology Dispensary, Ufa, Republic of Bashkortostan
Russian Federation
Russian Federation
Sh. R. Kzyrgalin
Bashkir State Medical University
Russian Federation
Russian Federation
References
1. Ганцев Ш.Х., Тимербулатов В.М., Огий И.И. и др. Диагностика и коррекция гемореологических расстройств у онкологических больных. М., 2008.
2. Бородин Ю.И., Сапин М.Р., Этинген Л.Е. и др. Общая анатомия лимфатической системы. Новосибирск: Наука, 1990; с. 224–41.
3. Dias S., Shmelkov S.V., Lam G., Rafii S. VEGF (165) promotes survival of leukemic cells by Hsp 90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood 2002;99:2532–40.
4. Dvorak H.F. Vascular permeability factor/ vascular endothelial growth factor: a critical cytokine in tumour angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002;20:4368–80.
5. Kabbinavar F., Hurwitz H.I., Fehrenbacher L. et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 2003;21:60–5.
6. Коненков В.И., Прокофьев В.Ф., Шевченко А.В., Зонова Е.В. Клеточная, сосудистая и экстрацеллюлярная составляющие лимфатической системы. Бюл СО РАМН 2008;133(5):7–13.
7. Абалмасов К.Г., Малинина А.А., Морозов К.М. и др. Повреждение регионарных лимфатических коллекторов в сосудистой хирургии. Грудн сердечно- сосуд хирург 1997;(2):129.
8. Спиридонов А.А., Абалмасов К.Г., Тутов Е.Г. и др. Лечение лимфатических осложнений после реконструктивных операций на магистральных сосудах. Анн хирург 1997;(1):33–7.
9. Фокин А.А., Кузнецов А.Г., Орехова Л.А. и др. Лучевое лечение лимфореи в паховой области после артериальной реконструкции. Ангиол сосуд хирург 2001; 7(1): 96–8.
10. Van Sonnenberg E., Wittich G.R., Casola G. et al. Lymphocoeles: imaging characteristics and percutaneous management. Radiology 1986;161:593–6.
Review
For citations:
Gantsev Sh.Kh., Sultanbayev A.V., Ishmuratova R.Sh., Frolova V.Yu., Kzyrgalin Sh.R. Time course of changes in the biochemical composition of peripheral lymph in breast cancer. Tumors of female reproductive system. 2011;(4):37-41. (In Russ.) https://doi.org/10.17650/1994-4098-2011-0-4-37-41
Views:
561
Email this article 